title: [Recurrent attacks of angioedema ascribed to the use of estrogen preparations and a pregnancy (hereditary angioedema type 3)].
abstract: A woman experienced recurrent attacks of angioedema from the age of 17 to 21 years and these appeared to be associated with the use of oestrogens. After stopping the medication her complaints disappeared, but they returned during her first pregnancy. Angioedema is a serious condition, which can lead to acute abdominal symptoms, oedema of the upper respiratory tract and death by asphyxiation. The most well-known cause is hereditary angioedema, an autosomal dominant disorder that is characterized by deficiency of C1 esterase inhibitor (C1-INH). Recently, a new type of hereditary angioedema (type 3) has been reported that occurs exclusively in women and is characterised by oestrogen dependency (both endogenous and exogenous), normal C1-INH concentrations and severe attacks of angioedema, which are clinically indistinguishable from the classic form.
authors.affiliation: Onze Lieve Vrouwe Gasthuis, afd. Intensivecaregeneeskunde, Postbus 95.500, 1090 HM Amsterdam. jmvanderklooster@planet.nl
authors.forename: J M
authors.initials: JM
authors.lastname: van der Klooster
authors.forename: L J D M
authors.initials: LJ
authors.lastname: Schelfhout
authors.forename: A F
authors.initials: AF
authors.lastname: Grootendorst
authors.forename: P G M A
authors.initials: PG
authors.lastname: Zweers
mesh_terms: D015746:Abdominal Pain / Q000209:etiology; D000293:Adolescent; D000328:Adult; D000799:Angioedema / Q000139:chemically induced* / Q000150:complications / Q000235:genetics*; D001327:Autoimmune Diseases; D003174:Complement C1 Inactivator Proteins / Q000172:deficiency* / Q000235:genetics; D004967:Estrogens / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications; D012008:Recurrence
chemical_list: D003174:Complement C1 Inactivator Proteins; D004967:Estrogens